1. Unnikrishnan R, Anjana RM, Mohan V. Diabetes mellitus and its complications in India. Nat Rev Endocrinol. 2016; 12(6): 357-70. doi:10.1038/nrendo.2016.53 PMid:27080137

2. Zimmet P, Alberti K, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001; 414 (6865):782-7. doi:10.1038/414782a PMid:11742409

3. Thomas NJ, Walkey HC, Kaur A, Misra S, Oliver NS, Colclough K, et al. The relationship between islet autoantibody status and the genetic risk of type 1 diabetes in adult-onset type 1 diabetes. Diabetologia. 2023; 66 (2): 310-20. doi:10.1007/s00125-022-05823-1 PMid:36355183 PMCid:PMC9807542

4. Tomita T. Apoptosis of pancreatic β-cells in Type 1 diabetes. Bosn J Basic Med Sci. 2017;17(3):183-93. doi:10.17305/bjbms.2017.1961 PMid:28368239 PMCid:PMC5581966

5. Aguayo-Mazzucato C, Diaque P, Hernandez S, Rosas S, Kostic A, Caballero AE, et al. Understanding the growing epidemic of type 2 diabetes in the Hispanic population living in the United States. Diabetes Metab Res Rev. 2019; 35(2):e3097. doi:10.1002/dmrr.3097 PMid:30445663 PMCid:PMC6953173

6. Chidhambara PD, Raj DS, Kumar VP, Sankaran U. Experimental animal models for diabetes and its related complications-a review. Lab Anim Res. 2021;37:127-40. doi:10.1186/s42826-021-00101-4 PMid:34429169 PMCid:PMC8385906

7. Fadini GP, Ferraro F, Quaini F, Asahara T, Madeddu P. Concise review: diabetes, the bone marrow niche, and impaired vascular regeneration. Stem Cells Transl Med. 2014; 3(8):949-57. doi:10.5966/sctm.2013-0195 PMid:24646489 PMCid:PMC4006490

8. Kim TY, Schafer AL. Diabetes and bone marrow adiposity. Curr Osteoporos Rep. 2016;14(6):337-44. doi:10.1007/s11914-016-0336-x PMid:27714580 PMCid:PMC5126977

9. Stookey J, Burg M, Sellmeyer DE, Greenleaf JE, Arieff A, Van Hove L, Gardner C, King JC. A proposed method for assessing plasma hypertonicity in vivo. Eur J Clin Nutr. 2007; 61(1): 143-6. doi:10.1038/sj.ejcn.1602484 PMid:16835598

10. Collister D, Rigatto C, Tangri N. Anemia management in chronic kidney disease and dialysis: a narrative review. Curr Opin Nephrol Hypertens. 2017; 26(3): 214-8. doi:10.1097/MNH.0000000000000317 PMid:28306566

11. Nekoui A, Blaise G. Erythropoietin and nonhematopoietic effects. Am J Med Sci. 2017; 353 (1): 76-81. doi:10.1016/j.amjms.2016.10.009 PMid:28104107

12. McGill JB, Bell DS. Anemia and the role of erythropoietin in diabetes. J Diabetes Complicat. 2006; 20 (4): 262-72. doi:10.1016/j.jdiacomp.2005.07.005 PMid:16798472

13. Suresh S, Alvarez JC, Dey S, Noguchi CT. Erythropoietin-induced changes in bone and bone marrow in mouse models of diet-induced obesity. Int J Mol Sci. 2020;21(5):1657. doi:10.3390/ijms21051657 PMid:32121294 PMCid:PMC7084787

14. Samy A, El-Adl M, Rezk S, Marghani B, Eldomany W, Eldesoky A, et al. The potential protective and therapeutic effects of platelet-rich plasma on ischemia/reperfusion injury following experimental torsion/detorsion of testis in the Albino rat model. Life Sci. 2020;256:117982. doi:10.1016/j.lfs.2020.117982 PMid:32562693

15. Alves R, Grimalt R. A review of platelet-rich plasma: history, biology, mechanism of action, and classification. Skin Appendage Disord. 2018; 4(1): 18-24. doi:10.1159/000477353 PMid:29457008 PMCid:PMC5806188

16. Ehrenfest DMD, Andia I, Zumstein MA, Zhang CQ, Pinto NR, Bielecki T, et al. Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives. Muscles Ligaments Tendons J. 2014;4(1):3-9. doi: 10.11138/mltj/2014.4.1.003

17. El-Tahawy NF, Rifaai RA, Saber EA, Saied SR, Ibrahim RA. Effect of platelet-rich plasma (PRP) injection on the endocrine pancreas of the experimentally induced diabetes in male albino rats: a histological and immunohistochemical study. J Diabetes Metab. 2017;8 (730): 2. doi:10.4172/2155-6156.1000730

18. Hafez SMNA, Zenhom NM, Abdel-Hamid HA. Effects of platelet-rich plasma on experimentally induced diabetic heart injury. Int Immunopharmacol. 2021; 96: 107814. doi:10.1016/j.intimp.2021.107814 PMid:34162165

19. Wang-Fischer Y, Garyantes T. Improving the reliability and utility of streptozotocin-induced rat diabetic model. J Diabetes Res. 2018;2018:8054073. doi:10.1155/2018/8054073 PMid:30345315 PMCid:PMC6174751

20. Zarin M, Karbalaei N, Keshtgar S, Nemati M. Platelet-rich plasma improves impaired glucose hemostasis, disrupted insulin secretion, and pancreatic oxidative stress in streptozotocin-induced diabetic rat. Growth Factors. 2019; 37(5-6):226-37. doi:10.1080/08977194.2020.1735382 PMid:32151173

21. Mazzanti L, et al. Diabetes mellitus induces red blood cell plasma membrane alterations possibly affecting the aging process. Clin Biochem. 1992; 25(1):41-6. doi:10.1016/0009-9120(92)80044-H PMid:1312917

22. Chang HY, Li X, Karniadakis GE. Modeling of biomechanics and biorheology of red blood cells in type 2 diabetes mellitus. Biophys J. 2017;113(2):481-90. doi:10.1016/j.bpj.2017.06.014 PMid:28746857 PMCid:PMC5529610

23. Zaki MK, Abed MN, Alassaf FA. The regulatory role of erythropoietin in diabetes mellitus: a focus on oxidative and glycemic statuses. Rom J Med Pract. 2024;19(2):1-6. doi:10.37897/RJMP.2024.2.6

24. Lian Z, Yin X, Li H, Jia L, He X, Yan Y, et al. Synergistic effect of bone marrow-derived mesenchymal stem cells and platelet-rich plasma in streptozotocin-induced diabetic rats. Ann Dermatol. 2014; 26(1):1-10. doi:10.5021/ad.2014.26.1.1 PMid:24648680 PMCid:PMC3956772

25. Graves DT, Liu R, Alikhani M, Al-Mashat H, Trackman PC. Diabetes-enhanced inflammation and apoptosis-impact on periodontal pathology. J Dent Res. 2006;85(1):15-21. doi:10.1177/154405910608500103 PMid:16373675

26. Peng B, Kong G, Yang C, Ming Y. Erythropoietin and its derivatives: from tissue protection to immune regulation. Cell Death Dis. 2020;11(2):79. doi:10.1038/s41419-020-2276-8 PMid:32015330 PMCid:PMC6997384

27. Bakadia BM, Ahmed AAQ, Lamboni L, Shi Z, Mukole BM, Zheng R, et al. Engineering homologous platelet-rich plasma, platelet-rich plasma-derived exosomes, and mesenchymal stem cell-derived exosomes-based dual-crosslinked hydrogels as bioactive diabetic wound dressings. Bioact Mater. 2023; 28: 74-94. doi:10.1016/j.bioactmat.2023.05.002 PMid:37234363 PMCid:PMC10206161

28. OuYang H, Tang Y, Yang F, Ren X, Yang J, Cao H, et al. Platelet-rich plasma for the treatment of diabetic foot ulcer: a systematic review. Front Endocrinol. 2023;14: 1256081. doi:10.3389/fendo.2023.1256081 PMid:38169990 PMCid:PMC10760804

29. Antoniadou C, Gavriilidis E, Ritis K, Tsilingiris D. Anemia in Diabetes Mellitus: pathogenetic aspects and the value of early erythropoietin therapy. Metab Open. 2025; 100344. doi:10.1016/j.metop.2024.100344 PMid:39886103 PMCid:PMC11780985